Clinical factors identify scleroderma patients at risk of PAH


Australian research has identified clinical and serological risk factors predictive of pulmonary arterial hypertension (PAH) in both sub-types of systemic sclerosis. Lead researcher and rheumatologist Dr Mandana Nikpour, from the University of Melbourne and St Vincent’s Hospital, told the limbic the models might eventually help refine screening algorithms for what is the leading cause of ...


Already a member? Login to keep reading


OR
© 2017 the limbic